Core Laboratories (CLB) Total Non-Current Liabilities (2022 - 2025)
Core Laboratories (CLB) has 4 years of Total Non-Current Liabilities data on record, last reported at $298.6 million in Q3 2025.
- For Q3 2025, Total Non-Current Liabilities fell 7.79% year-over-year to $298.6 million; the TTM value through Sep 2025 reached $298.6 million, down 7.79%, while the annual FY2024 figure was $317.7 million, 5.61% down from the prior year.
- Total Non-Current Liabilities reached $298.6 million in Q3 2025 per CLB's latest filing, down from $312.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $368.5 million in Q4 2022 and bottomed at $298.6 million in Q3 2025.
- Average Total Non-Current Liabilities over 4 years is $331.7 million, with a median of $331.8 million recorded in 2024.
- Peak YoY movement for Total Non-Current Liabilities: fell 8.68% in 2023, then fell 5.61% in 2024.
- A 4-year view of Total Non-Current Liabilities shows it stood at $368.5 million in 2022, then dropped by 8.68% to $336.5 million in 2023, then decreased by 5.61% to $317.7 million in 2024, then dropped by 6.02% to $298.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $298.6 million in Q3 2025, $312.9 million in Q2 2025, and $311.2 million in Q1 2025.